Researchers from Inserm and the NeuroCentre Magendie (Bordeaux) published a fascinating study in August 2025: they successfully stimulated mitochondrial activity
Mitochondrial diseases are rare, complex, and often misdiagnosed. This is why MITOMICS, an ambitious French project funded as part of
MEET THE PEOPLE BEHIND Epilepsy Plus – E+ Introducing Emma Del Rey, E+ consultant, Board Member of International Mito Patients,
The FDA (U.S. Food and Drug Administration) has just approved Kygevvi, the first treatment for thymidine kinase 2 deficiency (TK2d),
Many voices, one mission. 53 associations united for people with rare and complex epilepsies (E+). E+ is not limited to
MARK YOUR CALENDAR: November 15, 2025 Day dedicated to the transition to adulthood for adolescents with rare diseases: TOULOUSE This
Sheba Medical Center (Israel) has launched the very first clinical trial of mitochondrial cell therapy to treat Pearson Syndrome, a
conducted by Nice University Hospital, and more specifically by the CALISSON Reference Center for Mitochondrial Diseases from Childhood to Adulthood,
These cellular powerhouses have their own DNA (mtDNA), inaccessible to CRISPR-Cas9 tools, which frustrates research. CRISPR (Clustered Regularly Interspaced Short
The 4th edition of the RSBA, the Animated Sport and Happiness Hike, is coming! This Sunday, October 19, starting at
Tonight at 7 PM, worldwide, a wave of light will sweep across the night . Candles will be lit to
On October 7 & 8, our President Emma Del-Rey proudly represents the A.M.Mi Association at the Rare Disease Meetings 2025
Association for Mitochondrial Diseases
6, impasse Jacques Prévert
31470 Sainte-Foy-de-Peyrolières
Phone: +33 6 30 84 58 27
Email: assoammi@gmail.com
A.M.Mi is a co-founder and member of:
© AMMi 2025 – All rights reserved – WordPress site expertise and development by www.md-webdesigner.com
